Stockreport

ARS Pharmaceuticals Announces Conference Call and Webcast for its Third Quarter 2025 Financial Results

ARS Pharmaceuticals, Inc.  (SPRY) 
PDF SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their c [Read more]